2028年までの北米医療大麻市場予測 - 新型コロナウイルス感染症の影響と地域分析 - 製品タイプ別（乾燥形態および抽出形態）、用途別（疼痛管理、トゥレット病、アルツハイマー病、片頭痛、うつ病および不安症、多発性硬化症、がん、その他）、および流通チャネル（小売薬局、電子商取引、その他）
北米の医療大麻市場は、2022 年の 71 億 7,017 万米ドルから 2028 年までに 207 億 6,041 万米ドルに成長すると予想されています。2022 年から 2028 年にかけて 19.4% の CAGR を記録すると推定されています。 ;
医療用マリファナ製品の承認の増加が北米の医療用マリファナ市場の成長を促進
< p>マリファナの薬効に注目して、さまざまな研究者や企業が医療用途でマリファナを使用するようになりました。たとえば、テトラヒドロカンナビノール (THC) は主に医薬品の製造に使用されます。米国食品医薬品局（FDA）は、有効成分としてナボリンを含むセサメットなどのTHCベースの医薬品を承認していますが、これはTHCと同様の構造を持つ合成由来の製品です。セサメットは、化学療法を受けている患者の吐き気の治療に処方されます。セサメットは通常、他の薬で吐き気や嘔吐をコントロールできない場合に処方されます。 FDA はまた、米国での治療用途としてマリノールとシンドロスを承認しました。マリノールとシンドロには、大麻の精神活性成分と考えられる合成 9-THC である有効成分ドロナビノールが含まれています。マリノール薬とシンドロス薬は、エイズの適応症の 1 つとして開発された消耗症候群の患者の食欲を刺激するために処方されます。同様に、さまざまなマリファナベースの製品が承認されているか、臨床試験中です。たとえば、ナビキシモール (Sativex) はカナダで商業化されている承認薬です。ナビキシモルスは、多発性硬化症に関連する痙縮や神経因性疼痛の治療に使用される大麻抽出物です。 THCと他のカンナビジオール（CBD）を組み合わせて配合されています。 2020年2月、カナダの企業であるCanaQuest Medical Corpは、カナダ保健省にメンタビノールの製造および商業化の承認を申請した。メンタビノールはTHCベースの製品であり、その承認申請は大麻法に基づいて提出されています。 FDA による上記のマリファナベースの製品の承認の増加が医療用マリファナ市場を牽引しています。北米の医療用マリファナ市場の概要
北米の医療大麻市場は、米国、カナダ、メキシコに分割されています。医療大麻市場は米国で最大のシェアを持っていると推定されています。医療大麻市場の成長は、革新的な治療応用を探るための研究と協力の増加、医療大麻に対する意識の高まり、そしてこの地域における主要企業の存在に起因すると考えられます。さらに、地域全体で高齢化人口が増加していることも市場の成長に有利となるでしょう。
北米の医療大麻市場の収益と 2028 年までの予測 (米国) 100 万ドル)
北米の医療用マリファナ市場セグメンテーション
北米の医療大麻市場は、製品タイプ、用途、流通チャネル、国に分割されています。
北米の医療大麻市場は、製品の種類に基づいて、乾燥形態と抽出形態に分類されます。エキスフォームセグメントは、2022 年の北米医療大麻市場で大きなシェアを占めました。
適用に基づいて、北米医療大麻市場は疼痛管理、トゥレット病、アルツハイマー病、片頭痛、うつ病と不安症、多発性硬化症、がんなど。疼痛管理セグメントは、2022 年の北米医療大麻市場で最大のシェアを占めました。
流通チャネルに基づいて、北米の医療大麻市場は小売薬局、および小売薬局に分類されます。 -商業、その他。小売薬局セグメントは、2022 年の北米医療大麻市場で最大のシェアを占めました。
北米の医療大麻市場は国別に、米国、カナダ、そしてメキシコ。 2022 年の北米医療大麻市場は米国が独占しました。
Aphria, Inc.;カナクエスト医療法人;キャノピー・グロース・コーポレーション;エメラルド ヘルス セラピューティクス株式会社; GWファーマシューティカルズ;株式会社マリキャン；オーガニグラムホールディングス株式会社;パナクシア製薬工業株式会社;フェナホールディングス株式会社;と VIVO Cannabis Inc は、北米の医療大麻市場で事業を展開する大手企業です。
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Medical Marijuana Market – by Product
1.3.2 North America Medical Marijuana Market – by Application
1.3.3 North America Medical Marijuana Market – by Distribution Channel
1.3.4 North America Medical Marijuana Market – by Country
2. North America Medical Marijuana Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Medical Marijuana Market – Market Landscape
4.1 Overview
4.2 North America – PEST Analysis
4.3 Expert Opinion
5. North America Medical Marijuana Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Approvals of Medical Marijuana Products
5.1.2 Rising Acceptance of Medicinal Use of Marijuana in America
5.2 Market Restraints
5.2.1 Illegal Use of Cannabis as Street Drug and Misconceptions Regarding Marijuana
5.3 Market Opportunities
5.3.1 Increase in Job Opportunities in Marijuana Industry
5.4 Future Trends
5.4.1 Widespread Distribution of Medical Marijuana
5.5 Impact Analysis
6. Medical Marijuana Market – North America Analysis
6.1 North America Medical Marijuana Market Revenue Forecast and Analysis
7. North America Medical Marijuana Market Revenue and Forecast To 2028– by Product
7.1 Overview
7.2 North America Medical Marijuana Market Revenue Share, by Product (2021 and 2028)
7.3 Dried Form
7.3.1 Overview
7.3.2 Dried Form: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Extract Form
7.4.1 Overview
7.4.2 Extract Form: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
8. North America Medical Marijuana Market Analysis – by Application
8.1 Overview
8.2 North America Medical Marijuana Market Revenue Share, by Application (2021 and 2028)
8.3 Pain Management
8.3.1 Overview
8.3.2 Pain Management: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Tourette’s
8.4.1 Overview
8.4.2 Tourette’s: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Alzheimer’s Disease
8.5.1 Overview
8.5.2 Alzheimer’s Disease: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Migraines
8.6.1 Overview
8.6.2 Migraines: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Depression and Anxiety
8.7.1 Overview
8.7.2 Depression and Anxiety: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Multiple Sclerosis
8.8.1 Overview
8.8.2 Multiple Sclerosis: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
8.9 Cancer
8.9.1 Overview
8.9.2 Cancer: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
8.10 Others
8.10.1 Overview
8.10.2 Others: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Medical Marijuana Market – by Distribution Channel
9.1 Overview
9.2 North America Medical Marijuana Market, by Distribution Channel (2021 and 2028)
9.3 Retail Pharmacy
9.3.1 Overview
9.3.2 Retail Pharmacy: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
9.4 E-Commerce
9.4.1 Overview
9.4.2 E-commerce: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
10. North America Medical Marijuana Market Revenue and Forecast to 2028 – Country Analysis
10.1 Overview
10.1.1 North America Medical Marijuana Market, by Country, 2021 & 2028 (%)
10.1.1.1 US: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 US: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.2 US: Medical Marijuana Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 US: Medical Marijuana Market, by Application– Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.4 US: Medical Marijuana Market, Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2 Canada: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Canada: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.2 Canada: Medical Marijuana Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Canada: Medical Marijuana Market, by Application– Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.4 Canada: Medical Marijuana Market, Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3 Mexico: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Mexico: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.2 Mexico: Medical Marijuana Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 Mexico: Medical Marijuana Market, by Application– Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.4 Mexico: Medical Marijuana Market, Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
11. North America Medical Marijuana Market – Industry Landscape
11.1 Overview
11.2 Growth Strategies in the North America Medical Marijuana Market (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 VIVO Cannabis Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Panaxia Pharmaceutical Industries Ltd.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Phoena Holdings Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Emerald Health Therapeutics Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 MARICANN INC.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Aphria, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Canopy Growth Corporation
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 CanaQuest Medical Corporation
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 GW Pharmaceuticals
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Organigram Holdings Inc.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms for North America Medical Marijuana Market
LIST OF TABLES
Table 1. US: Medical Marijuana Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 2. US: Medical Marijuana Market, by Application – Revenue and Forecast to 2028 (US$ Million).
Table 3. US: Medical Marijuana Market, Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 4. Canada: Medical Marijuana Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 5. Canada: Medical Marijuana Market, by Application – Revenue and Forecast to 2028 (US$ Million).
Table 6. Canada: Medical Marijuana Market, Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 7. Mexico: Medical Marijuana Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 8. Mexico: Medical Marijuana Market, by Application – Revenue and Forecast to 2028 (US$ Million).
Table 9. Mexico: Medical Marijuana Market, Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 10. Organic Developments in the Medical Marijuana Market
Table 11. Inorganic Developments in the Medical Marijuana Market
Table 12. Glossary of Terms for North America Medical Marijuana Market
LIST OF FIGURES
Figure 1. North America Medical Marijuana Market Segmentation
Figure 2. North America Medical Marijuana Market, By Country
Figure 3. North America Medical Marijuana Market Overview
Figure 4. Extract Form Held Largest Share of Product Segment in Medical Marijuana Market
Figure 5. US to Show Remarkable Growth During Forecast Period
Figure 6. North America PEST Analysis
Figure 7. North America Medical Marijuana Market– Revenue Forecast and Analysis – 2020- 2028
Figure 8. North America Medical Marijuana Market Revenue Share, by Product (2021 and 2028)
Figure 9. Dried Form: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. Extract Form: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. North America Medical Marijuana Market Revenue Share, by Application (2021 and 2028)
Figure 12. Pain Management: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Tourette’s: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Alzheimer’s Disease: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Migraines: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Depression and Anxiety: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Multiple Sclerosis: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Cancer: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Others: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. North America Medical Marijuana Market, by Distribution Channel (2021 and 2028)
Figure 21. Retail Pharmacy: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. E-commerce: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Others: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. North America Medical Marijuana Market, by Key Country – Revenue (2021) (US$ Million)
Figure 25. North America Medical Marijuana Market, by Country, 2021 & 2028 (%)
Figure 26. US: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Canada: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Mexico: North America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Growth Strategies in the North America Medical Marijuana Market (%)
- Aphria, Inc.
- CanaQuest Medical Corporation
- Canopy Growth Corporation
- Emerald Health Therapeutics Inc.
- GW Pharmaceuticals
- MARICANN INC.
- Organigram Holdings Inc.
- Panaxia Pharmaceutical Industries Ltd.
- Phoena Holdings Inc.
- VIVO Cannabis Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America medical marijuana market .
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in North America medical marijuana market , thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.